The leading outsource provider to law firm, in-house and sole practitioner patent attorneys.
Learn more
Our proven search methods and detailed results enable our clients to make strategic business assessments ahead of their competitors.
Learn More
Will you be prepared for the new standard?
WIPO ST.26 will be here soon.
Timely posts of the latest Intellectual Property, FDA, legal and business news as it relates to the biotech, chemical, agricultural and pharmaceutical industries.
Learn More
We are the leading outsource provider to law firm, in-house, and sole practitioner patent attorneys and agents for meeting US (37 CFR §§1.821-.825) and foreign (WIPO Standard ST.25) Sequence Listing requirements.
Leading law firms and companies use Harbor Consulting's expertise in the life sciences arena to perform biosequence, chemical structure, and full text searches for a variety of purposes.
The Committee for WIPO Standards completed its Sixth Session at the end of October. On the agenda were various items pertaining to the adoption and transition to WIPO ST.26.
Various items have been decided upon, including:
• The transition will happen via the "big bang" scenario in January 2022.
• The International Bureau will develop a new common software tool for preparation and verification of Sequence Listings
• The Task Force will support the International Bureau with user requirements and feedback on the software.
The EPO, JPO, KIPO and USPTO have outlined their plans as we approach 2022 and many strategic changes need to happen over the next three years in order for implementation to be successful including ST.26 software development, software testing, analysis/revisions of current processes, and implementation. Please don't hesitate to contact us if you have any questions!